Contract award · 3 Feb 2021

Lanadelumab Injection - Shire

Belfast Health and Social Care Trust awarded “Lanadelumab Injection - Shire” to Shire Pharmaceuticals (part of Takeda Pharmaceutical Company) for £300k on 3 Feb 2021. Awarded without open competition.

No competitionMedical equipment & pharmaceuticalsNorthern Ireland

Awarded without open competition

Awarded without open competition. The buyer went directly to one or a few suppliers instead of advertising the contract. Procurement rules allow this only in specific cases, such as extreme urgency, when only one supplier can do the work, or for call-offs from an existing framework.

What “without competition” means

Key facts

Buyer
Belfast Health and Social Care Trust · Body governed by public law
Value
£300,000
Procedure
Award procedure without prior publication of a call for competition
Sector
Medical equipment & pharmaceuticals · Medical equipments, pharmaceuticals and personal care products (CPV 33000000)
Timeline
  1. Contract date3 Feb 2021
  2. Published12 Feb 2021Published 9 days after the contract date

Description

Lanadelumab Injection - Shire

About the supplier

More from Belfast Health and Social Care Trust

All contracts

Recent medical equipment & pharmaceuticals contracts

Sector overview